Mahajan Imaging Neuberg Diagnostics joint venture
Analysis based on 15 articles · First reported Aug 31, 2026 · Last updated Sep 01, 2026
The joint venture strengthens both companies' positions in India's growing organized diagnostics market, potentially boosting revenue growth. It may increase competition in the sector and attract investor attention to diagnostic healthcare providers.
Mahajan Imaging & Labs and Neuberg Diagnostics have entered into a strategic joint venture to expand pathology, genomics, and wellness services across North India. The partnership combines Mahajan Imaging & Labs' expertise in radiology, nuclear medicine, PET CT, and advanced diagnostics with Neuberg's pathology and genomics capabilities, clinical and operational expertise, and multi-market experience across India, the UAE, South Africa, and the USA. The joint venture will enhance testing across genomics, metabolomics, proteomics, and molecular pathology. Kabir Mahajan will serve as CEO of the joint venture. The partnership comes as ICRA Limited estimates 12-14% revenue growth for organized diagnostic players in FY2027. Financial details were not disclosed. The transaction was advised by Kornerstone Advisors, EY, C&S Partners, Alvarez and Marsal, Dhruva Advisors, Khaitan & Co, and Deloitte.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard